MSD Australia and New Zealand Revenue and Competitors

Blenheim Road, AU

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • MSD Australia and New Zealand's estimated annual revenue is currently $82.2M per year.(i)
  • MSD Australia and New Zealand's estimated revenue per employee is $201,000

Employee Data

  • MSD Australia and New Zealand has 409 Employees.(i)
  • MSD Australia and New Zealand grew their employee count by 26% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.1M2649%N/AN/A
#2
$24.7M12326%N/AN/A
#3
$20.5M102-1%N/AN/A
#4
$16.1M8014%N/AN/A
#5
$18.7M932%N/AN/A
#6
$64.1M31919%N/AN/A
#7
$48.8M2435%N/AN/A
#8
$33.8M1687%N/AN/A
#9
$29.7M14815%N/AN/A
#10
$67.3M3352%N/AN/A
Add Company

Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. In Australia, our headquarters are in Sydney, and Auckland for New Zealand. Today's MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information about MSD in Australia, visit www.msd-australia.com.au. For more information about MSD in New Zealand http://www.msd-newzealand.com. You can also connect with us on Twitter, Facebook and YouTube. Prescription medicines, Over the counter medicines, Animal Health medicines

keywords:N/A

N/A

Total Funding

409

Number of Employees

$82.2M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MSD Australia and New Zealand News

2022-04-17 - Can we request him to come out of retirement?': Ex-India pacer wants Dhoni back

Former India pacer wants Dhoni to return for T20 World Cup in Australia ... friends has tweeted his desire to see MSD come out of retirement...

2022-03-30 - An important month for PTE in Australia: what pharmaceutical ...

Australia's patent term extension (PTE) provisions are rarely out of the ... MSD v Sandoz – PTE must be based on the earliest listed product...

2022-03-22 - Patent term extensions in Australia - further challenges for ...

The Full Court decisions in MSD v Sandoz and Ono, and the APO's decision in Bayer, demonstrate the challenges pharmaceutical patentees face in...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$107.6M410-26%N/A
#2
$35M42722%N/A
#3
$35M461N/AN/A
#4
$111.4M495N/AN/A
#5
$92.3M509N/AN/A

MSD Australia and New Zealand Executives


NameTitle
Wayne SparksIT Director(CIO)